ArticleTheranostics2012
Quantum dots: an insight and perspective of their biological interaction and how this relates to their relevance for clinical use.
Article in Theranostics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Exploring the potential and safety of quantum dots in allergy diagnostics.Microsystems & nanoengineering · 2023Review
- Semiconductor Quantum Dots as Target Analytes: Properties, Surface Chemistry and Detection.Nanomaterials (Basel, Switzerland) · 2022Review
- Biomedical Applications of Quantum Dots: Overview, Challenges, and Clinical Potential.International journal of nanomedicine · 2022Review
- New Generation of Photosensitizers Based on Inorganic Nanomaterials.Methods in molecular biology (Clifton, N.J.) · 2022Review
- Nanomaterials-Based Biosensors for COVID-19 Detection-A Review.IEEE sensors journal · 2021Article
- Natural carbon-based quantum dots and their applications in drug delivery: A review.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020Review
- Revisiting the cytotoxicity of quantum dots: an in-depth overview.Biophysical reviews · 2020Review
- Strategies for Image-Guided Therapy, Surgery, and Drug Delivery Using Photoacoustic Imaging.Theranostics · 2019Review
- Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.International journal of molecular sciences · 2017Review
- Cytotoxicity investigation of luminescent nanohybrids based on chitosan and carboxymethyl chitosan conjugated with BiToxicology research · 2016Article
- Drug Carrier for Photodynamic Cancer Therapy.International journal of molecular sciences · 2015Review
- Polymeric materials for theranostic applications.Pharmaceutical research · 2014Review
- Targeted therapy using nanotechnology: focus on cancer.International journal of nanomedicine · 2014Review
- Selective inhibition of liver cancer growth realized by the intrinsic toxicity of a quantum dot-lipid complex.International journal of nanomedicine · 2014Article
- Effect of injection routes on the biodistribution, clearance, and tumor uptake of carbon dots.ACS nano · 2013Article
- Selective Effects of Curcumin on CdSe/ZnS Quantum-dot-induced Phototoxicity Using UVA Irradiation in Normal Human Lymphocytes and Leukemia Cells.Toxicological research · 2013Article
- Quantum dots for biophotonics.Theranostics · 2012Article
- Surface biofunctionalized CdS and ZnS quantum dot nanoconjugates for nanomedicine and oncology: to be or not to be nanotoxic?International journal of nanomedicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to their novel physico-chemical characteristics, semi-conductor nanocrystal quantum dots (QDs) provide an advantageous perspective towards numerous different consumer and medical applications. The most notable potential application of QDs is their use as therapeutic and diagnostic tools in nanomedicine. Despite the many benefits posed by QDs, the proposed, intentional exposure to humans has raised concerns towards their potential impact upon human health. These concerns are predominantly based upon the heterogeneous composition of QDs, which most commonly comprises of a cadmium-based core and zinc sulphide shell. Whilst other nanoparticle (NP) types possess a similar structure to QDs (i.e. core-shell technology (e.g. Fe(2)O(3), Au and superparamagnetic iron oxide NPs)), the importance of the concerns surrounding human exposure to QDs is amplified further since, due to the sophisticated chemical and light-emitting properties of QDs, the use of these NPs within any (nano)medical setting/application could be suggested as realistic, rather than simply an advantageous possibility. It is therefore imperative that a thorough understanding of how QDs interact with various biological systems, predominantly those relative to humans and what the consequences of such interactions are is gained with extreme alacrity. It is the aim of this review to highlight the current knowledge base of QD-biological system interactions, where the knowledge gaps (still) remain and how the understanding of this interaction relates to the most notable of applications for QDs; their clinical relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.